Author:
Hsu Che-Chia,Ko Po-Yen,Kwan Ting-Hsien,Liu Ming-Yie,Jou I.-Ming,Lin Chi-Wei,Wu Po-Ting
Abstract
AbstractEstrogen deficiency is one of the main causes of postmenopausal osteoporosis in elderly women. Hormone replacement therapy has been employed to manage postmenopausal osteoporosis; however, it has raised concerns related to heart attacks and breast cancer. Sesame oil has been reported to affect sex hormone status. The aim of the present study is to evaluate the effect of sesame oil supplement on postmenopausal osteoporosis in rats. We used female Sprague Dawley rats that underwent bilaterally ovariectomy (OVX) as an experimental postmenopausal osteoporosis animal model. These rats were orally administrated sesame oil (0.25 or 0.5 mL/kg/day) for four months as the therapeutic group. We assessed bone mineral density (BMD) and the levels of osteocalcin, procollagen-I C-terminal propeptide (PICP), collagen cross-linked N-telopeptide (NTx), estradiol, and aromatase in the sera. The daily supplementation of sesame oil significantly increased BMD, serum osteocalcin levels, and trabecular areas in the OVX-treated rats. Sesame oil also elevated serum PICP levels and decreased NTx levels in these rats. Furthermore, sesame oil effectively maintained serum estradiol and aromatase levels in the OVX-induced osteoporosis rats. In conclusion, daily supplementation of sesame oil prevents postmenopausal osteoporosis by maintaining serum estrogen and aromatase levels, while also modulating the imbalance between bone formation and resorption in osteoporosis rats.
Funder
National Science and Technology Council
National Cheng Kung University
National Cheng Kung University Hospital
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Weitzmann, M. N. & Pacifici, R. Estrogen deficiency and bone loss: An inflammatory tale. J. Clin. Investig. 116, 1186–1194 (2006).
2. Adami, G. et al. Osteoporosis in 10 years time: A glimpse into the future of osteoporosis. Ther. Adv. Musculoskelet. Dis. 14, 1759720X221083541 (2022).
3. Iwamoto, J., Sato, Y., Takeda, T. & Matsumoto, H. Whole body vibration exercise improves body balance and walking velocity in postmenopausal osteoporotic women treated with alendronate: Galileo and Alendronate Intervention Trail (GAIT). J. Musculoskelet. Neuronal. Interact. 12, 136–143 (2012).
4. Tavani, A. & La Vecchia, C. The adverse effects of hormone replacement therapy. Drugs Aging 14, 347–357 (1999).
5. Doherty, D., Sanders, K., Kotowicz, M. & Prince, R. Lifetime and five-year age-specific risks of first and subsequent osteoporotic fractures in postmenopausal women. Osteoporos. Int. 12, 16–23 (2001).